Log in to save to my catalogue

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for...

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2337472e7e294d978b5c5f262eb34a8c

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis

About this item

Full title

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2021-12, Vol.11 (12), p.199-199, Article 199

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Arterial (AT) and venous (VT) thrombotic events are the most common complications in patients with polycythemia vera (PV) and are the leading causes of morbidity and mortality. In this regard, the impact of
JAK2
V617F variant allele frequency (VAF) is still debated. The purpose of the current study was to analyze the impact of
JAK2
V617...

Alternative Titles

Full title

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2337472e7e294d978b5c5f262eb34a8c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2337472e7e294d978b5c5f262eb34a8c

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-021-00581-6

How to access this item